Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford has signed a collaborative agreement with biotechnology firm SomaLogic.

The agreement will see the partners undertake a number of collaborative projects that will employ SomaLogic's proprietary SOMAmer® reagents and SOMAscan® assay technologies to discover and characterize protein biomarkers for a range of clinical diseases and conditions.

In order to maximize the collaborative nature of these projects and accelerate the translation of discoveries into clinical testing, the agreement also includes the build-out of a SOMAscan assay service laboratory at Oxford under the direction of SomaLogic personnel.

Read more

Similar stories

Oxford Researchers elected to Royal Society

Awards and Appointments General

Six scientists from the University of Oxford, including Professor Adrian Hill and Professor Frances Platt from the Medical Sciences Division, have joined the Royal Society as Fellows.

Student Prizes for Biomedical Sciences and Medicine 2020-2021

Awards and Appointments General

Congratulations to all our Biomedical Sciences students and Medicine students who have been awarded prizes during the 2020-2021 academic year.

Multi-partner 'OpenMind' consortium to develop technology for new generation of neurostimulation devices

General Research

Investigators at the University of Oxford, University of California San Francisco (UCSF), Brown University and the Mayo Clinic have joined forces to develop open-source technology platforms for a new generation of neurostimulation devices that not only provide stimulation to the brain but also sense, record, and stream brain activity.

Why we must expand newborn screening

General Research

Professor Laurent Servais of the Department of Paeditrics writes for the Oxford Science Blog on why it is important that we become much more efficient in the diagnosis of treatable conditions and in the treatment of these diseases.

Top place for Oxford Clinical Medical Student in prestigious national Ophthalmology Duke Elder Prize Examination

Awards and Appointments General

Sixth year Clinical Medical student, Ryan Purdy (Worcester College), placed first in the Royal College of Ophthalmology's annual Prize Examination.